About the Juvenile Idiopathic Arthritis Working Group

Juvenile idiopathic arthritis (JIA) is the most common rheumatologic disease of childhood and a cause of acquired disability. Multiple outcome measurement sets are currently used in studies of JIA.

Since 2015, the OMERACT JIA Core Set Working Group has obtained global stakeholder input from patients with JIA, caregivers, healthcare providers (HCP), and researchers to update the JIA Core Domain Set

Alessandro Consolaro

Alessandro Consolaro

Co-Chair

esi

Esi Morgan, MD, MSCE

Co-Chair

Jane Munro

Jane Munro

Co-Chair

Balay_Erin 001

Erin Balay-Dustrude, MD

Fellow

Ben Horgan

Ben Horgan

Patient Research Partner

Jennifer Horonjeff

Jennifer Horonjeff

Patient Research Partner

OMERACT Endorsed Core Domain Set for Juvenile Idiopathic Arthritis

OMERACT Onions with Instruments

JIA OVERVIEW VIDEO

RECENT WORKING GROUP PUBLICATIONS

  1. Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group

  2. Establishing an updated core domain set for clinical trials and longitudinal studies in juvenile idiopathic arthritis: a report from the OMERACT 13 JIA Workshop

  3. Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016

Scroll to Top